1393814-38-4

1393814-38-4 structure

Name: TC LPA5 4
Chemical Name: 5-(3-chloro-4-cyclohexylphenyl)-1-(3-methoxyphenyl)-1H-pyrazole-3-carboxylic acid
CAS Number: 1393814-38-4
Molecular Formula: C₂₃H₂₃ClN₂O₃
Molecular Weight: 410.89
Catalog: Signaling Pathways GPCR/G Protein LPL Receptor
Create Date: 2016-12-11 12:07:55
Modify Date: 2025-09-18 08:34:04
TC LPA5 4 is a LPA5 (GPR92)-specific non-lipid antagonist. TC LPA5 4 inhibits LPA-induced aggregation of isolated human platelet (LPA5-RH7777 cell line) with an IC50 of 800 nM. TC LPA5 4 displays selectivity for LPA5 over 80 other screened drug targets[1]. TC LPA5 4 inhibits cell proliferation and migration of thyroid cancer cells[2].

Name	5-(3-chloro-4-cyclohexylphenyl)-1-(3-methoxyphenyl)-1H-pyrazole-3-carboxylic acid

Description	TC LPA5 4 is a LPA5 (GPR92)-specific non-lipid antagonist. TC LPA5 4 inhibits LPA-induced aggregation of isolated human platelet (LPA5-RH7777 cell line) with an IC50 of 800 nM. TC LPA5 4 displays selectivity for LPA5 over 80 other screened drug targets[1]. TC LPA5 4 inhibits cell proliferation and migration of thyroid cancer cells[2].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> GPCR/G Protein >> LPL Receptor
In Vitro	TC LPA5 4 inhibits the proliferation on thyroid cancer cells CGTH-W3, TPC-1, B-CAPAP, and BHT101 significantly with IC50 at 103.0 μM, 84.9 μM, 55.9μM, and 57.17 μM. TC LPA5 4 (5 μM; 24 hours) significantly inhibits LPA-stimulated migration of CGTH-W3 and TPC-1 cells, with an inhibitory rate of ~ 30%. B-CPAP and BHT101 cells expressed higher LPAR5 mRNA. TC LPA5 4 inhibits these two cell lines’ proliferations with IC50 at 55.9μM and 57.17 μM. CGTH-W3 and TPC-1 cells expressed lower LPAR5 mRNA. TC LPA5 4 displays differential antitumor activity with IC50 at 103.0 μM and 84.9 μM[2].
In Vivo	TC LPA5 4 (10 mg/kg; intraperitoneal injection; 5 days/week for 2 weeks) could delay CGTH-W3 xenograft growth in nude mice[2]. Animal Model: BALB/C nu/nu mice, aged 4 5 weeks (CGTH-W3 xenografts) [2] Dosage: 10 mg/kg Administration: Intraperitoneal injection; 5 days/week for 2 weeks Result: Significantly inhibits CGTH-W3 xenograft growth with inhibitory rates of 46.7%.
References	[1]. Kozian DH, et al. Selective non-lipid modulator of LPA5 activity in human platelets. Bioorg Med Chem Lett. 2012;22(16):5239-5243. [2]. Zhao WJ, et al. LPAR5 promotes thyroid carcinoma cell proliferation and migration by activating class IA PI3K catalytic subunit p110β. Cancer Sci. 2021;112(4):1624-1632.

Molecular Formula	C₂₃H₂₃ClN₂O₃
Molecular Weight	410.89
Exact Mass	410.14000
PSA	64.35000
LogP	5.94720

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.

1393814-38-4	864756-35-4
871307-18-5	1415407-60-1
1324003-64-6	494191-73-0
1431540-99-6	873398-67-5
1159996-20-9	1021912-42-4
2758000-85-8	2757925-33-8
2757956-32-2	2382408-91-3
2227876-46-0	2228667-41-0
2137721-57-2	2002187-08-6
2016500-07-3	1690857-93-2